Pharmafile Logo

Indegene

Patient Engagement for the Life Sciences

Patient Engagement for the Life Sciences, written by Guy Yeoman and Mitchell Silva with editorial and design support from Cuttsy+Cuttsy, explains the ‘why’ and the ‘how’ of patient engagement. It...

Cuttsy + Cuttsy

Patient Engagement Book Image

Moving away from pharma’s paternalistic approach

New handbook makes the case for greater patient engagement in the development of new medicines

Cuttsy + Cuttsy

- PMLiVE

VC raises new €270m fund for European biotechs

The money will mostly go to companies working on novel therapies

- PMLiVE

Changes to look out for in Medical Devices Regulations

Will digital lead to a greater compliance burden?

- PMLiVE

Breakthrough Device status for novel blood filtering immunotherapy

Novel technology aims to reactivate immune system in cancer patients

- PMLiVE

Healthcare sector ‘lacks awareness’ of cybersecurity threats

RAE report suggests medical devices could be prone to cyber attacks

- PMLiVE

The bulk of pharma digital spend fails to alter industry’s greenhorn status

Indegene’s Digital Maturity study reveals huge gaps in KPIs

- PMLiVE

Pulling together

Making sense of the present and future environment for the life science sector in the UK

Tightening medical device safety

European legislators seek to reduce patient exposure to safety risks

FDA poised to start digital health pilot

Forms a key part of the agency's new digital innovation action plan

- PMLiVE

UK life sciences sector sets out its post-Brexit growth proposals

Review helmed by Sir John Bell outlines a wide-ranging strategy

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links